Keytruda Extends Life for Those Fighting Hodgkin Lymphoma & It’s Now FDA-Approved as Treatment

Published Oct 19, 2020

Keytruda Extends Life for Those Fighting Hodgkin Lymphoma & It’s Now FDA-Approved as Treatment

People with relapsed or treatment-resistant classic Hodgkin Lymphoma now have FDA approval to use Keytruda. The immunotherapy treatment is proven to extend life.

NOW
PLAYING
Actress Lena Dunham, 35, Has Some Choice Words About Body Image For Internet Trolls; How to Achieve Body Positivity After Cancer
NOW
PLAYING
'American Ninja Warrior' Contestant Overcame Cancer but Still Suffers from Memory Loss; Exercise Can Reduce Chemo Brain
NOW
PLAYING
'Dexter' Star and Lymphoma Survivor Michael C. Hall Returns to His Character with Ease
NOW
PLAYING
ENHERTU Is A 'Big Game Changer' for HER2 Positive Metastatic Breast Cancer Patients
NOW
PLAYING
New Hope for Patients With Cervical Cancer: Adding Immunotherapy Drug to Standard Chemo Treatment Could Improve Survival Time
NOW
PLAYING
Jeff Bridges Announces His Cancer Remission and a Recovery from COVID-19

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.